Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Europe dares to reopen as 200 millionth vaccine dose delivered

Mon, 10th May 2021 13:41

By Michael Gore and Estelle Shirbon

MADRID/LONDON, May 10 (Reuters) - As its vaccination drive
reaches a third of adults and COVID-19 infections ease, Europe
is starting to reopen cities and beaches, raising hopes that
this summer's holiday season can be saved before it is too late.

Exhilarated Spaniards chanting "freedom" danced in the
streets as a COVID-19 curfew ended in most of the country at the
weekend, while Greece reopened public beaches - with deckchairs
safely spaced.

With 200 million vaccine doses delivered, the European Union
is on track to achieve its goal of inoculating 70% of its adult
population by summer, Commission President Ursula von der Leyen
tweeted on Sunday.

And, in Germany, a first weekend of summer sun lifted
spirits after Health Minister Jens Spahn declared the third wave
of the pandemic finally broken.

Yet, Spahn warned: "The mood is better than the reality."

The national seven-day incidence of COVID-19 cases remains
high at 119 per 100,000 people, he said. "That makes it all the
more important to keep up the speed of the vaccination
campaign."

Across the EU, the seven-day incidence of COVID-19 is 185,
according to Our World in Data. That is far higher than in
countries such as Israel with 6, Britain (31), or the United
States (123), all of which made quicker early progress in their
vaccination drives.

HEAD START

In Britain, early orders and approval of vaccines and a
decision to give first doses to as many people as possible have
driven down infections and fatalities far more quickly.

Prime Minister Boris Johnson was expected to set out the
next phase of lockdown easing in England, giving the green light
to "cautious hugging" and allowing pubs to serve customers pints
inside after months of strict measures.

"The data reflects what we already knew - we are not going
to let this virus beat us," Johnson said ahead of an official
announcement later on Monday.

Vaccine deliveries were slower initially in the EU under its
centralised procurement strategy.

Now, with shots from BioNTech/Pfizer and Moderna relatively
plentiful, vaccinations as a share of the population in Europe
are growing while countries that made early advances see
slowdowns as they encounter hesitancy among the unvaccinated.

Some 31.6% of adults in 30 European countries have received
a first dose and 12% a full two-shot regime, the European Centre
for Disease Prevention and Control's COVID-19 Vaccine Tracker https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab
showed.

France expects to give 20 million first injections by
mid-May, and hit 30 million by mid-June.

With infection rates falling and occupancy in hospital
intensive care units declining, France plans to start relaxing
its curfew and allow cafes, bars and restaurants to offer
outdoor service from May 19.

PICKING AND CHOOSING

Improving supply has given countries greater freedom to
adapt their strategies following reports of very rare, but
sometimes fatal, blood clotting in people who received shots
from AstraZeneca and Johnson & Johnson.

Germany has decided to make the two vaccines available to
anyone who wants them, as long as they have been advised by a
doctor - an offer aimed at younger adults who would have to wait
their turn otherwise.

Norway's vaccine commission made a similar call on Monday,
saying the AstraZeneca and J&J shots should be made available to
volunteers. Some Italian regions are also offering both shots to
people under 60.

With some governments shortening the gaps between doses, and
plans for an EU digital "green pass" scheme in June for
travellers to provide proof of vaccination or immunity, people
cooped up for months are finally daring to make holiday plans.

"We're pinning our hopes on tourism," said Nikos Venieris,
who manages a beach in Alimos, an Athens suburb.

Tourism accounts for about a fifth of Greece's economy and
jobs, and the country can ill afford another lost summer. Greece
is lifting restrictions on vaccinated foreigners from May 15.

(Writing by Douglas Busvine
Additional reporting by Jordi Rubio, Terje Solsvik, Gwladys
Fouche, Matthias Blamont, Emilio Parodi, John Miller, Alan
Charlish and Phoebe Fronista
Editing by Giles Elgood)

More News
23 Oct 2023 17:08

LONDON MARKET CLOSE: Stocks largely down on Middle East hostilities

(Alliance News) - Stock prices in London closed largely lower on Monday, as investors were unable to shake off concerns surrounding the conflict in the Middle East, while developments in the US bond market added to the drama.

Read more
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 07:43

LONDON BRIEFING: Stocks seen lower; Aviva buys AIG's UK protection arm

(Alliance News) - Stocks in London were set to open lower on Monday as investors eyed fresh concerns for the already fragile Chinese property sector.

Read more
22 Sep 2023 08:42

LONDON MARKET OPEN: Stocks slip after central bank rate calls

(Alliance News) - Stock prices in London opened lower on Friday, but managed to avoid the steep declines seen in New York, as investors mulled over an eventful week dominated by central bank decisions.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.